roses and candy | Horse Racing Free Tips

McAnally Trainee Disqualified Over CBD Positive; Separate Hearing To Determine Sanctions

Roses and Candy, winner of the third race at Del Mar on Nov. 22, 2020, has been disqualified by the California Horse Racing Board after testing positive for a metabolite of the Class 1 drug 7-Carboxy-Cannabidiol, reports the Thoroughbred Daily News. A separate hearing will be held to determine whether any sanctions will be handed down to the mare's trainer, Hall of Famer Ron McAnally.

Better known as CBD – and marketed widely for a variety of health benefits to humans – Cannabidiol is found in a number of equine products, including tincture oil, pellets, liniment spray and poultices. While it is believed to work as an anti-inflammatory there is limited research on the possible benefits of CBD in horses and its use remains controversial. Because it is not included in the CHRB's classification list of drugs, it becomes a Class 1/Penalty Class A by default, according to CHRB spokesman Mike Marten.

The TDN reports that under CHRB rules, first-time violations of penalty class A can lead to a minimum one-year suspension or maximum three-year suspension, with a maximum fine of $25,000, absent mitigating circumstances.

The Association of Racing Commissioners International lists Cannabidiol as a Class 2/Penalty Category B substance, and the CHRB began the process of changing CBD's classification in early 2021. On Jan. 21, the CHRB pushed back the proposed rule change to make Cannabidiol a Class 3/Penalty Category B drug to the February meeting, at which point it went out for public comment.

The complaint was not made public until May 17, 2021.

CBD is now listed as a Class 3/Penalty Category B drug, for which first-time violations can result in a fine of no more than $10,000 and a minimum 30-day suspension, absent mitigating circumstances.

According to a report in Daily Racing Form, jockey Geovanni Franco, who rode Roses and Candy to victory Nov. 22, admitted to McAnally assistant Dan Landers that he used a product containing CBD the day of the race. Roses and Candy won the day's third race. Geovanni rode another winner on the same card three hours later that did not test positive.

Read more at the Thoroughbred Daily News.

The post McAnally Trainee Disqualified Over CBD Positive; Separate Hearing To Determine Sanctions appeared first on Horse Racing News | Paulick Report.

Source of original post

McAnally-Trained Mare DQ’d In Year-Old CBD Case

A mare trained by 89-year-old Hall-of-Fame trainer Ron McAnally has been disqualified after winning a race at Del Mar Thoroughbred Club last November and subsequently testing positive for a metabolite of cannabidiol (CBD).

A separate hearing to determine if McAnally will be further sanctioned will go before a hearing officer, California Horse Racing Board (CHRB) spokesperson Mike Marten told TDN.

[Note: A previous version of this story incorrectly stated McAnally had avoided being fined or suspended after the issuance of the CHRB's Nov. 12 ruling mandating the DQ.]

Roses and Candy (Candy Ride {Arg}), the nose victress of a Nov. 22, 2020, starter-allowance turf sprint tested positive post-race for 7-Carboxy-Cannabidiol.

The case stood out at the time the complaint was issued back in May for three reasons:

Firstly, it took nearly a half-year between the positive test and the issuance of a complaint.

Secondly, with regard to a possible accidental contamination, soon after the finding was discovered, jockey Geovanni Franco approached the CHRB to disclose that he had used a CBD-containing cream himself, perhaps triggering the mare's positive test when he rode her.

Thirdly, regarding the mechanism for penalization, CBD was not listed as a classified substance at the time the positive finding came back.

In California, by default, any unclassified positives are supposed to be treated as the most-severe Class 1, Penalty Category A violations. And under CHRB rules, such a serious first-time violation can lead to a minimum one-year suspension or a maximum three-year suspension, with a maximum fine of $25,000, absent mitigating circumstances.

But in the six-month gap between that November 2020 positive and when a complaint was eventually issued in May 2021, the CHRB was in the process of reclassifying CBD (and a number of other substances) to the less-severe 3B distinction, which is how the CBD offense is listed now. In California, first-time 3B violations can result in a fine of no more than $10,000 and a minimum 30-day suspension, absent mitigating circumstances.

Back on May 17, 2021, when the complaint became public, Marten told TDN that agency's staff would recommend to the stewards that they treat the positive as the lower 3B penalty because the new classifications had already been voted in by the board in February and were awaiting certification by California's Office of Administrative Law (OAL).

Two days later, at the monthly CHRB meeting on May 19, Rick Arthur, DVM, the CHRB's equine medical director at the time, said for the record, “Let me just get right to the heart of the issue. Cannabidiol, which was not classified under the current standard of regulation, was proposed to be a 3B in August of 2020, three or four months before this violation.”

As a result of the DQ ruling from last week, Roses and Candy's owner, Deborah McAnally, must forfeit $20,500 in purse winnings.

The post McAnally-Trained Mare DQ’d In Year-Old CBD Case appeared first on TDN | Thoroughbred Daily News | Horse Racing News, Results and Video | Thoroughbred Breeding and Auctions.

Source of original post

CHRB Files Medication Complaints Against Hall Of Famers McAnally, Mandella

The California Horse Racing Board has filed medication complaints against trainers Ron McAnally and Richard Mandella, two members of the National Museum of Racing and Hall of Fame who have rarely been cited for violations throughout their careers.

McAnally was notified of a positive test for the Class 1 drug 7-Carboxy-Cannabidiol in Roses and Candy, winner of the third race at Del Mar on Nov. 22, 2020. A split sample confirmed the presence of the substance.

Better known as CBD, Cannabidiol is found in a number of equine products, including tincture oil, pellets, liniment spray and poultices. While it is believed to work as an anti-inflammatory there is limited research on the possible benefits of CBD in horses and its use remains controversial. Because it is not included in the CHRB's classification list of drugs, it becomes a Class 1/Penalty Class A by default, according to CHRB spokesman Mike Marten. The Association of Racing Commissioners International lists Cannabidiol as a Class 2/Penalty Category B substance.

Marten said a proposed rule change to make Cannabidiol a Class 3/Penalty Category B drug is currently out for public comment and CHRB executive director Scott Chaney and investigators will recommend that stewards treat the alleged infraction as a Class 3 violation. It would still result in the disqualification of the horse, Marten added.

McAnally has not been sanctioned for any medication violations in California since 1998, Marten said. According to www.thoroughbredrulings.com, McAnally received a warning for a positive test for the Class D drug Cimetidine in Kentucky in 2009.

The CHRB filed a complaint against Mandella on May 7 after Jolie Olimpica – third in the Grade 3 San Simeon Stakes on March 13, 2021 – was found in a post-race sample to have 6.1 ng/ml of the Class 4/Penalty Category C drug methocarbamol – a muscle relaxant. A split sample confirmed the presence of the drug.

Mandella was fined $500 in January 2018 after two anti-inflammatories were found in a post-race sample – his most recent violation. He was also fined $500 for a methocarbamol positive in 2011.

Stewards hearings will be scheduled for both trainers.

The post CHRB Files Medication Complaints Against Hall Of Famers McAnally, Mandella appeared first on Horse Racing News | Paulick Report.

Source of original post